Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma.
Tetzlaff MT, Messina JL, Stein JE, Xu X, Amaria RN, Blank CU, van de Wiel BA, Ferguson PM, Rawson RV, Ross MI, Spillane AJ, Gershenwald JE, Saw RPM, van Akkooi ACJ, van Houdt WJ, Mitchell TC, Menzies AM, Long GV, Wargo JA, Davies MA, Prieto VG, Taube JM, Scolyer RA.
Ann Oncol. 2018 Aug 1;29(8):1861-1868. doi: 10.1093/annonc/mdy226.
PMID:29945191
Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group.
Provenzano E, Bossuyt V, Viale G, Cameron D, Badve S, Denkert C, MacGrogan G, Penault-Llorca F, Boughey J, Curigliano G, Dixon JM, Esserman L, Fastner G, Kuehn T, Peintinger F, von Minckwitz G, White J, Yang W, Symmans WF; Residual Disease Characterization Working Group of the Breast International Group-North American Breast Cancer Group Collaboration.
Mod Pathol. 2015 Sep;28(9):1185-201. doi: 10.1038/modpathol.2015.74. Epub 2015 Jul 24.
PMID:26205180
HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY.
KRASNOW N.
Am Heart J. 1965 Jun;69:820-33. doi: 10.1016/0002-8703(65)90457-6.
PMID:14300033
TRACHEOBRONCHOPATHIA OSTEOCHONDROPLASTICA.
SECREST PG, KENDIG TA, BELAND AJ.
Am J Med. 1964 May;36:815-8. doi: 10.1016/0002-9343(64)90189-5.